- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
- Angiogenesis as a part of the Tumor „Ecosystem“ and possibilities to influence it.2010 | First Faculty of Medicine
- Inhibition of angiogenesis in the treatment of tumors2010 | First Faculty of Medicine
- Aggressive Vertebral Hemangioma2015 | Faculty of Medicine in Hradec Králové
- Immunotherapy of renal cell carcinoma2018 | First Faculty of Medicine
- Pharmacotherapy in ophthalmology2009 | First Faculty of Medicine
- Avastin: a case report2010 | Faculty of Medicine in Pilsen
- Nintedanib - interesting alternative forsecond line pulmonaty adenocarcinoma patients2016 | Faculty of Medicine in Pilsen
- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- Nintedanib in the treatment of idiopathic pulmonary fibrosis2016 | First Faculty of Medicine
- Systemic therapy of lung adenocarcinoma2016 | Faculty of Medicine in Pilsen
- Biologic therapy of lung cancer2008 | Third Faculty of Medicine
- Angiogenic factors are elevated in overweight and obese individuals2005 | First Faculty of Medicine
- Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Role of Serum Levels of Angiogenic Cytokines in Assessment of Angiogenesis After Stem Cell Therapy of Diabetic Patients With Critical Limb Ischemia2014 | Faculty of Physical Education and Sport, Central Library of Charles University
- Regorafenib - role of the drug in the current real-life oncological practice2018 | Publication without faculty affiliation